Logo
x

Search category

Subscribe Now

All Posts by Date

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar- aflibercept) in Korea

Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar- aflibercept) in Korea

  • March 9, 2021
Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

  • March 9, 2021
TrinamiX Signs a Joint Development Agreement with VIAVI Solutions to Bring Near-Infrared Spectroscopy into Smartphones

TrinamiX Signs a Joint Development Agreement with VIAVI Solutions to Bring Near-Infrared Spectroscopy into Smartphones

  • March 9, 2021
Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US

Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US

  • March 9, 2021
Roche's Ventana ALK (D5F3) CDx Assay Receives the US FDA's Approval for the Treatment of ALK-Positive NSCLC

Roche's Ventana ALK (D5F3) CDx Assay Receives the US FDA's Approval for the Treatment of ALK-Positive NSCLC

  • March 9, 2021
Exelixis Signs an Exclusive License Agreement with WuXi Biologics to Expand its Growing Oncology Biologics Pipeline

Exelixis Signs an Exclusive License Agreement with WuXi Biologics to Expand its Growing Oncology Biologics Pipeline

  • March 9, 2021
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.